WHO Considers Use of Experimental Vaccines as Ebola Cases and Deaths Rise in DRC

The Democratic Republic of Congo (DRC) is grappling with a devastating Ebola outbreak, which has claimed at least 130 suspected lives and infected hundreds more. The World Health Organization’s (WHO) chief, Tedros Adhanom Ghebreyesus, has expressed deep concern over the speed and scale of the outbreak.

Behind the headlines lies a complex web of factors driving this crisis. The DRC’s porous border with South Sudan creates an ideal breeding ground for disease to spread due to conflict that has displaced thousands. Moreover, the region’s healthcare infrastructure is plagued by neglect.

Dr. Mesfin Teklu Tessema, senior director of health at the International Rescue Committee (IRC), which operates in the DRC’s Ituri Province, said: “We’re flying blind” because of a lack of access to basic protective equipment for healthcare workers. This highlights that Ebola outbreaks often thrive on weak public health systems.

Experts are working to understand the genetic makeup of the Bundibugyo strain responsible for this outbreak, which has no approved vaccine or treatment. The WHO has convened a technical group to advise on potential treatments, but even vaccines available for other strains may not be effective against this particular variant.

The DRC is no stranger to Ebola outbreaks, with nearly 2,300 lives lost in the deadliest outbreak between 2018 and 2020. Despite past lessons, the world seems to be repeating old mistakes, with the WHO warning that this outbreak could take a long time to bring under control.

This current outbreak’s speed and spread into urban areas and among health workers indicate a potentially complex and difficult-to-contain situation. This serves as a stark reminder of the dangers of complacency in public health, particularly when it comes to diseases that can spread quickly through human contact.

Conflict is at the heart of this crisis, driving neglect and displacement. Dr. Maria Guevara’s assessment that “the system is broken” in the DRC rings true, especially given the immense challenges posed by other diseases such as cholera and maternal mortality.

The international community must confront the reality that conflict can exacerbate public health crises by displacing populations, disrupting healthcare systems, and creating fertile ground for disease to spread. This is not just a humanitarian crisis but also an economic one, with long-term implications for stability in the region.

As the WHO convenes its technical group and the international community mobilizes aid, more than immediate medical interventions are needed. A sustained commitment to rebuilding healthcare infrastructure and supporting peace efforts is crucial to preventing future outbreaks.

The decision by some countries to ban travel from affected areas while others encourage screening at border crossings highlights a broader challenge: how to balance public health concerns with economic cooperation and stability in regions prone to conflict.

Ebola’s shadow looms large over not just the DRC but also global health security, serving as a stark reminder that our best efforts in healthcare are only as strong as our weakest link: human resilience, infrastructure, and collective will to act before it’s too late.